Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients

  • Minajeva A
  • Kase M
  • Saretok M
  • et al.
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glioblastoma (GB) is the most angiogenic tumor. Nevertheless, antiangiogenic therapy has not shown significant clinical efficacy. The aim of this study was to assess blood vessel characteristics on survival of GB patients. Surgically excised GB tissues were histologically examined for overall proportion of glomeruloid microvascular proliferation (MP) and the total number of blood vessels. Also, immunohistochemical vascular staining intensities of CD133 and ICAM-1 were determined. Vessel parameters were correlated with patients’ overall survival. The survival time depended on the number of blood vessels ( p = 0.03 ) but not on the proportion of MP. Median survival times for patients with low (

Cite

CITATION STYLE

APA

Minajeva, A., Kase, M., Saretok, M., Adamson-Raieste, A., Kase, S., Niinepuu, K., … Jaal, J. (2017). Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients. Neuroscience Journal, 2017, 1–8. https://doi.org/10.1155/2017/5629563

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free